BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 230 filers reported holding BEAM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $777,537 | -10.6% | 32,330 | +18.8% | 0.03% | -9.1% |
| Q2 2023 | $869,294 | -40.7% | 27,225 | -27.3% | 0.03% | -57.7% |
| Q4 2022 | $1,465,178 | -38.6% | 37,463 | -39.2% | 0.08% | -24.3% |
| Q2 2022 | $2,386,000 | -21.6% | 61,614 | +15.9% | 0.10% | -21.4% |
| Q1 2022 | $3,045,000 | +78.8% | 53,146 | +171.6% | 0.13% | +6.5% |
| Q3 2021 | $1,703,000 | -22.2% | 19,570 | -28.4% | 0.12% | -39.7% |
| Q1 2021 | $2,188,000 | – | 27,338 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |